Wird geladen...
Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendations
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment since their introduction ∼15 years ago. However, these monoclonal antibodies are associated with immune-related adverse events that can also affect the kidney, resulting in acute kidney injury (AKI), which is most commonly due...
Gespeichert in:
| Veröffentlicht in: | Clin Kidney J |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087122/ https://ncbi.nlm.nih.gov/pubmed/33970161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfab052 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|